AngioDynamics Reports Fiscal 2016 Second Quarter Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. W

Go back to AngioDynamics Reports Fiscal 2016 Second Quarter Results

AngioDynamics (ANGO) PT Cut at Piper Jaffray

January 8, 2016 7:34 AM EST

AngioDynamics (NASDAQ: ANGO) met expectations for its Q2 (Nov) revenues and earnings, but cut guidance for the remainder of the year as the vascular access business has been adjusting to a Q3 recall from last year. Piper Jaffray analyst, Thomas Gunderson, lowered numbers as a result.

The Morpheus product was taken off the market, and the sales force diverted effort to try to retain customers. Not only was retention more... More

AngioDynamics (ANGO) Reports In-Line Q2 EPS; Trims FY16 Outlook

January 7, 2016 4:05 PM EST

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $89.2 million versus the consensus estimate of $88.67 million.

GUIDANCE:

AngioDynamics sees Q3 2016 EPS of $0.10-$0.14, versus the consensus of $0.17. AngioDynamics sees... More